Drug facts
MoleculeFluticasone
Generics already compete: 10 makers on the market. 12 A-rated products from 9 makers substitute at the counter.
Cutivate was first approved by the FDA on 12/14/1990 under NDA 019957; the application holder is Fougera Pharmaceuticals LLC. The Orange Book lists NDA 019957 as discontinued.
The latest NADAC for FLUTICASONE PROPIONATE HFA 110 MCG INHALER is $13.56 per gram (as of 10/28/2026).
Holder Fougera Pharmaceuticals LLCApplication NDA 019957Approved 12/14/1990
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Cutivate patent listed in the Orange Book Orange Book
- Later patents, other products
- Armonair Digihaler 01/06/2041; Xhance 02/23/2036 Orange Book
02Competition
- Generics
- 10 generic makers Orange Book
- First generic approved
- 05/14/2004 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Fluticasone profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
- NADAC
- $13.56 per gramFLUTICASONE PROPIONATE HFA 110 MCG INHALER, mid-priced of 3 strengths, as of 10/28/2026 CMS NADAC
- Latest recall
- 02/14/2024Class II, Fluticasone Propionate Nasal Spray USP, Golden State Medical Supply Inc. FDA enforcement
04Product
- Application holder
- Fougera Pharmaceuticals LLC Orange Book
- Application
- NDA 019957 Orange Book
- First approved
- 12/14/1990 Orange Book
- Dosage forms
- aerosol, metered; cream; lotion; ointment; powder; spray, metered
- Routes
- inhalation, nasal, topical
- Other brand names
- Flonase Allergy ReliefFlovent Diskus 100Flovent Diskus 250Flovent Diskus 50Flovent HFAXhance
- Status
- NDA 019957 discontinued Orange Book
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.